ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)

SHA:603976 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	207.28	325.08	108.9	187.62	212.43	392.17
Short-Term Investments	-	156.59	-	-	-	-
Trading Asset Securities	150	-	140.58	250.11	159.06	254.76
Cash & Short-Term Investments	357.28	481.67	249.48	437.73	371.49	646.93
Cash Growth	31.69%	93.07%	-43.01%	17.83%	-42.58%	140.23%
Accounts Receivable	396.42	338.59	364.58	397.91	355.53	298.37
Other Receivables	4.61	4.29	4.15	5.51	20.26	2.86
Receivables	401.03	342.88	368.73	403.42	375.8	301.23
Inventory	192.29	230.39	250.48	197.14	209.43	190.5
Other Current Assets	169.88	8.45	7.17	12.87	35.03	12.45
Total Current Assets	1,120	1,063	875.86	1,051	991.75	1,151
Property, Plant & Equipment	758.45	782.23	859.67	919.49	909.85	665.86
Long-Term Investments	-	-	0.05	0.05	0.05	0.05
Other Intangible Assets	38.05	38.31	39.36	40.41	41.6	42.98
Long-Term Deferred Tax Assets	9.87	9.34	8.82	12.65	1.13	5.89
Long-Term Deferred Charges	1.45	1.64	2.23	2.74	3.9	4.27
Other Long-Term Assets	18.85	6.66	170.82	16.38	59.41	90.33
Total Assets	1,947	1,902	1,957	2,043	2,008	1,960

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	220.2	191.8	240.47	313.88	296.65	278.36
Accrued Expenses	12.97	25.58	22.81	23.82	20.68	26.4
Short-Term Debt	-	-	-	30	60	50
Current Portion of Leases	0.06	0.06	0.06	0.2	0.37	0.32
Current Income Taxes Payable	10.43	1.45	0.92	3.3	0.98	13.28
Current Unearned Revenue	5.98	4.19	3.39	4.61	6.77	6.76
Other Current Liabilities	7.16	2.06	2.43	3.63	4.22	3.06
Total Current Liabilities	256.8	225.14	270.08	379.44	389.66	378.18
Long-Term Debt	451.32	445.94	431.99	416.25	399.27	382.32
Long-Term Leases	0.01	0.01	0.03	0.06	0.54	0.91
Long-Term Unearned Revenue	27.02	25.3	31.3	31.61	28.63	30.72
Long-Term Deferred Tax Liabilities	-	-	-	-	5.37	2.4
Total Liabilities	735.16	696.39	733.4	827.37	823.47	794.53

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	151.2	151.2	151.2	151.2	151.2	151.2
Additional Paid-In Capital	555.71	555.71	555.63	555.63	555.63	555.59
Retained Earnings	480.76	473.93	492.22	484.34	453.03	434.82
Comprehensive Income & Other	24.34	24.34	24.35	24.35	24.35	24.35
Shareholders' Equity	1,212	1,205	1,223	1,216	1,184	1,166
Total Liabilities & Equity	1,947	1,902	1,957	2,043	2,008	1,960

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	451.39	446.01	432.08	446.51	460.17	433.55
Net Cash (Debt)	-94.11	35.66	-182.6	-8.78	-88.68	213.38
Net Cash Growth	-	-	-	-	-	-2.81%
Net Cash Per Share	-0.67	0.25	-1.20	-0.06	-0.59	1.42
Filing Date Shares Outstanding	151.2	151.2	151.2	151.2	151.2	151.2
Total Common Shares Outstanding	151.2	151.2	151.2	151.2	151.2	151.2
Working Capital	863.69	838.26	605.78	671.72	602.08	772.92
Book Value Per Share	8.02	7.97	8.09	8.04	7.83	7.71
Tangible Book Value	1,174	1,167	1,184	1,175	1,143	1,123
Tangible Book Value Per Share	7.76	7.72	7.83	7.77	7.56	7.43
Buildings	-	459.38	466.94	467.67	362.71	359.42
Machinery	-	933.13	902.78	926.75	734.29	608.03
Construction In Progress	-	35.27	52.03	10.97	198.58	20.21

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error